4.44 USD
-0.06 (-1.33%)
4.44 USD
0 (0%)
Overall SBC gets a fundamental rating of 5 out of 10. We evaluated SBC against 101 industry peers in the Health Care Providers & Services industry. While SBC has a great health rating, its profitability is only average at the moment. SBC has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
SBC had positive earnings in the past year.
SBC had a negative operating cash flow in the past year.
1.2 Ratios
SBC's Return On Assets of 13.48% is amongst the best of the industry. SBC outperforms 98.02% of its industry peers.
SBC's Return On Equity of 17.47% is amongst the best of the industry. SBC outperforms 84.16% of its industry peers.
SBC has a better Return On Invested Capital (21.24%) than 94.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROIC | 21.24% |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 24.28%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Operating Margin value of 41.70%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Gross Margin value of 74.09%, SBC belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SBC is creating value.
Compared to 1 year ago, SBC has less shares outstanding
The debt/assets ratio for SBC has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.71 indicates that SBC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.71, SBC belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
SBC has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.07, SBC is doing good in the industry, outperforming 78.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.71 |
ROIC/WACC2.4
WACC8.84%
2.3 Liquidity
SBC has a Current Ratio of 5.10. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
SBC has a Current ratio of 5.10. This is amongst the best in the industry. SBC outperforms 93.07% of its industry peers.
SBC has a Quick Ratio of 5.06. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SBC (5.06) is better than 93.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 48.69% over the past year.
The Revenue has grown by 10.85% in the past year. This is quite good.
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
3.2 Future
The Earnings Per Share is expected to decrease by -0.28% on average over the next years.
SBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.61% yearly.
EPS Next Y-25.49%
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue Next Year-17.72%
Revenue Next 2Y-6.27%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.22, which indicates a very decent valuation of SBC.
Based on the Price/Earnings ratio, SBC is valued cheaper than 96.04% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.17. SBC is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 8.88, the valuation of SBC can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 96.04% of the companies listed in the same industry.
SBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.22 | ||
| Fwd PE | 8.88 |
4.2 Price Multiples
95.05% of the companies in the same industry are more expensive than SBC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.54 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%
5. Dividend
5.1 Amount
SBC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
4.44
-0.06 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.84%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap455.46M
Revenue(TTM)178.46M
Net Income(TTM)43.32M
Analysts80
Price Target8.33 (87.61%)
Short Float %1.46%
Short Ratio2.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.91%
EPS NY rev (3m)2.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-1.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.22 | ||
| Fwd PE | 8.88 | ||
| P/S | 2.55 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.84 | ||
| P/tB | 2.07 | ||
| EV/EBITDA | 4.54 |
EPS(TTM)0.54
EY12.16%
EPS(NY)0.5
Fwd EY11.26%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROCE | 26.89% | ||
| ROIC | 21.24% | ||
| ROICexc | 39.36% | ||
| ROICexgc | 48.54% | ||
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% | ||
| FCFM | N/A |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 69.08% | ||
| Cap/Sales | 1.14% | ||
| Interest Coverage | 636.56 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 | ||
| Altman-Z | 6.71 |
F-Score5
WACC8.84%
ROIC/WACC2.4
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-25.49%
EPS Next 2Y-8.79%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
Revenue Next Year-17.72%
Revenue Next 2Y-6.27%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A
SBC MEDICAL GROUP HOLDINGS I / SBC FAQ
What is the fundamental rating for SBC stock?
ChartMill assigns a fundamental rating of 5 / 10 to SBC.
Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?
ChartMill assigns a valuation rating of 5 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.
How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.
How financially healthy is SBC MEDICAL GROUP HOLDINGS I?
The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.
Can you provide the expected EPS growth for SBC stock?
The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -25.49% in the next year.